In addition, a combination of lopinavir and ritonavir known under the brand name Kaletra is subjected to drug interaction through inhibition of CYP3A and P‐glycoprotein, leading to ventricular arrhythmia. The gene discussed is CYP3A4; the disease is Ventricular arrhythmia.